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Abstract 
Review on ID2, with data on DNA/RNA, on the 
protein encoded and where the gene is implicated. 
Identity 
Other names: GIG8, ID2A, ID2H, bHLHb26 
HGNC (Hugo): ID2 
Location: 2p25.1 
 
 
DNA/RNA 
Description 
The gene spans 5608 bp containing 5 exons of 
which 2 (exons 3 and 4) are protein-encoding. 
Transcription 
The ID2 gene has 4 transcripts, of which 3 can 
generate functional protein: ID2-001 (2041bp) 
contains all 5 exons, ID2-201 (1362 bp) contains 3 
exons and ID2-002 contains 2 exons. ID2-003 (474 
bp) contains a retained intron. 
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Pseudogene 
A pseudogene of ID2 is located on chromosome 3. 
Protein 
Description 
ID2 belongs to the helix-loop-helix (HLH) protein 
family. It is composed by 134 aa and belongs to a 
subgroup HLH family members (ID1, ID2, ID3, 
ID4) that lack a basic DNA-binding domain. ID 
proteins form heterodimers with class I basic HLH-
group members such as MyoD (Langlands et al., 
1997), NEDD9 (Law et al., 1999), and E2A gene 
products E12 and E47. ID2 has a main domain 
located on 38-79 aa responsible for the helix-loop-
helix conformation. In addition, Id2 contains a 10 
aa motif that is responsible for the nuclear export 
signaling. 
Expression 
Expression of ID2 is found in the brain, ovary, 
liver, lung, thyroid gland and prostate and several 
subsets of leukocytes. ID2 expression is especially 
high in Natural Killer (NK-) cells, but is also found 
in CD4+ T cells, CD8+ T cells, monocytes and 
precursor B cells. 
Localisation 
Nucleus. 
Function 
Although it does not bind directly to DNA, by 
binding basic helix-loop-helix transcription factors 
through its HLH motif, ID2 may control tissue-
specific genes related to cell growth, proliferation 
and differentiation (Hara et al., 1994; Iavarone et 
al., 1994). ID2 functions in cell fate decisions in 
early leukocyte development. Specifically, ID2 is 
required for NK-cell, innate lymphoid and 
lymphoid tissue inducer cells (Boos et al., 2007; 
Moro et al., 2010; Yokota et al., 1999). 
Furthermore, ID2 functions in the development of 
several dendritic cell subsets: Langerhans cells, 
cutaneous dendritic cells and splenic CD8a+ 
dendritic cells (Hacker et al., 2003). Although ID2 
seems redundant for T-cell development in thymus, 
ID2 promotes NKT-cell development (Verykokakis 
et al., 2013), and it is involved in effector 
differentiation (Masson et al., 2013), as well as γδT 
cell homeostasis (Zhang et al., 2014). Finally, ID2 
inhibits progression of precursor-B-cell 
development (Hara et al., 1997; Jensen et al., 2013), 
as well as activation-induced deaminase expression 
during B-cell responses (Gonda et al., 2003), likely 
through inhibition of E47 (Sayegh et al., 2003). 
Besides leukocytes, ID2 has been found to function 
in erythrocyte development (Ji et al., 2008), 
enterocyte precursor and lung epithelial cell 
differentiation in mice (Rawlins et al., 2009). 
Furthermore, female mice lacking ID2 show 
lactation defects (Mori et al., 2000), and male mice 
have impaired spermatogenesis (Sablitzky et al., 
1998). 
Homology 
ID2 is highly conserved in vertebrates, including 
mammals, reptiles, and fish. 
Mutations 
Germinal 
No germinal mutations have been reported. 
Somatic 
No somatic mutations have been reported. 
Implicated in 
Neuroblastoma 
Note 
ID2 functions as a key regulator in the phenotypic 
transition of neuroblastoma tumor cells 
(Chakrabarti et al., 2013). Anchorage-dependent 
(AD) neuroblastoma cells express much higher 
levels of ID2 than anchorage-independent (AI) 
cells. Moreover, knockdown of ID2 in AD cells 
induces an AI phenotype, whereas the opposite is 
seen upon forced expression of ID2 in AI cells. The 
function of ID2 in this process is at least in part via 
negative regulation of the TGFβ/Smad pathway. 
Colon carcinoma 
Note 
ID2 expression is upregulated by enhanced beta-
catenin signaling and subsequent beta-catenin /TCF 
mediated transcription.  
The induction of ID2 expression increases 
anchorage-independent survival of these cells 
(Rockman et al., 2001). 
Melanoma 
Note 
The transition of melanoma to a more aggressive 
malignancy is associated with the resistance to 
growth inhibition by TGF-β (Javelaud et al., 2008). 
In susceptible cells, TGF-β suppresses ID2 
expression and allows p15lnk4b to induce a cell cycle 
arrest (Schlegel et al., 2009). Upon obtaining 
resistance to TGF-β, the tumor cells overexpress 
ID2 and remain in cycle. 
Retinoblastoma 
Note 
ID2 is overexpressed due to transcriptional 
activation by oncoproteins of the Myc family in 
retinoblastoma, where it is thought to inhibit 
Retinoblastoma protein family members (Lasorella 
et al., 2000; Lasorella et al., 2005). 
ID2 (inhibitor of DNA binding 2, dominant negative helix-loop-
helix protein) 
van Zelm MC 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2015; 19(3) 170 
Hodgkin's lymphoma 
Note 
The majority of Hodgkin's lymphomas are derived 
from germinal center B cells. Still, Hodgkin-
Reed/Sternberg (HRS) cells of classical Hodgkin's 
lymphoma have a very atypical phenotype.  
This is the result of overexpression of ABF-1 and 
Id2, which inhibit the function of the B cell-
determining transcription factor E2A (Mathas et al., 
2006; Renne et al., 2006).  
The mechanism resulting in ID2 overexpression, 
nor the impact of ID2 on cell cycle progression in 
HRS cells have been demonstrated experimentally 
yet (Cotta and Medeiros, 2008). 
References 
Hara E, Yamaguchi T, Nojima H, Ide T, Campisi J, 
Okayama H, Oda K. Id-related genes encoding helix-loop-
helix proteins are required for G1 progression and are 
repressed in senescent human fibroblasts. J Biol Chem. 
1994 Jan 21;269(3):2139-45 
Iavarone A, Garg P, Lasorella A, Hsu J, Israel MA. The 
helix-loop-helix protein Id-2 enhances cell proliferation and 
binds to the retinoblastoma protein. Genes Dev. 1994 Jun 
1;8(11):1270-84 
Hara E, Hall M, Peters G. Cdk2-dependent 
phosphorylation of Id2 modulates activity of E2A-related 
transcription factors. EMBO J. 1997 Jan 15;16(2):332-42 
Langlands K, Yin X, Anand G, Prochownik EV. Differential 
interactions of Id proteins with basic-helix-loop-helix 
transcription factors. J Biol Chem. 1997 Aug 
8;272(32):19785-93 
Sablitzky F, Moore A, Bromley M, Deed RW, Newton JS, 
Norton JD. Stage- and subcellular-specific expression of Id 
proteins in male germ and Sertoli cells implicates 
distinctive regulatory roles for Id proteins during meiosis, 
spermatogenesis, and Sertoli cell function. Cell Growth 
Differ. 1998 Dec;9(12):1015-24 
Law SF, Zhang YZ, Fashena SJ, Toby G, Estojak J, 
Golemis EA. Dimerization of the docking/adaptor protein 
HEF1 via a carboxy-terminal helix-loop-helix domain. Exp 
Cell Res. 1999 Oct 10;252(1):224-35 
Yokota Y, Mansouri A, Mori S, Sugawara S, Adachi S, 
Nishikawa S, Gruss P. Development of peripheral 
lymphoid organs and natural killer cells depends on the 
helix-loop-helix inhibitor Id2. Nature. 1999 Feb 
25;397(6721):702-6 
Lasorella A, Noseda M, Beyna M, Yokota Y, Iavarone A. 
Id2 is a retinoblastoma protein target and mediates 
signalling by Myc oncoproteins. Nature. 2000 Oct 
5;407(6804):592-8 
Mori S, Nishikawa SI, Yokota Y. Lactation defect in mice 
lacking the helix-loop-helix inhibitor Id2. EMBO J. 2000 
Nov 1;19(21):5772-81 
Rockman SP, Currie SA, Ciavarella M, Vincan E, Dow C, 
Thomas RJ, Phillips WA. Id2 is a target of the beta-
catenin/T cell factor pathway in colon carcinoma. J Biol 
Chem. 2001 Nov 30;276(48):45113-9 
Gonda H, Sugai M, Nambu Y, Katakai T, Agata Y, Mori KJ, 
Yokota Y, Shimizu A. The balance between Pax5 and Id2 
activities is the key to AID gene expression. J Exp Med. 
2003 Nov 3;198(9):1427-37 
Hacker C, Kirsch RD, Ju XS, Hieronymus T, Gust TC, Kuhl 
C, Jorgas T, Kurz SM, Rose-John S, Yokota Y, Zenke M. 
Transcriptional profiling identifies Id2 function in dendritic 
cell development. Nat Immunol. 2003 Apr;4(4):380-6 
Sayegh CE, Quong MW, Agata Y, Murre C. E-proteins 
directly regulate expression of activation-induced 
deaminase in mature B cells. Nat Immunol. 2003 
Jun;4(6):586-93 
Lasorella A, Rothschild G, Yokota Y, Russell RG, Iavarone 
A. Id2 mediates tumor initiation, proliferation, and 
angiogenesis in Rb mutant mice. Mol Cell Biol. 2005 
May;25(9):3563-74 
Mathas S, Janz M, Hummel F, Hummel M, Wollert-Wulf B, 
Lusatis S, Anagnostopoulos I, Lietz A, Sigvardsson M, 
Jundt F, Jöhrens K, Bommert K, Stein H, Dörken B. 
Intrinsic inhibition of transcription factor E2A by HLH 
proteins ABF-1 and Id2 mediates reprogramming of 
neoplastic B cells in Hodgkin lymphoma. Nat Immunol. 
2006 Feb;7(2):207-15 
Renné C, Martin-Subero JI, Eickernjäger M, Hansmann 
ML, Küppers R, Siebert R, Bräuninger A. Aberrant 
expression of ID2, a suppressor of B-cell-specific gene 
expression, in Hodgkin's lymphoma. Am J Pathol. 2006 
Aug;169(2):655-64 
Boos MD, Yokota Y, Eberl G, Kee BL. Mature natural killer 
cell and lymphoid tissue-inducing cell development 
requires Id2-mediated suppression of E protein activity. J 
Exp Med. 2007 May 14;204(5):1119-30 
Cotta CV, Medeiros LJ. Expression of helix-loop-helix 
proteins in classical hodgkin lymphoma: a possible 
explanation for a characteristic immunophenotype. Adv 
Anat Pathol. 2008 Mar;15(2):97-104 
Javelaud D, Alexaki VI, Mauviel A. Transforming growth 
factor-beta in cutaneous melanoma. Pigment Cell 
Melanoma Res. 2008 Apr;21(2):123-32 
Ji M, Li H, Suh HC, Klarmann KD, Yokota Y, Keller JR. Id2 
intrinsically regulates lymphoid and erythroid development 
via interaction with different target proteins. Blood. 2008 
Aug 15;112(4):1068-77 
Rawlins EL, Clark CP, Xue Y, Hogan BL. The Id2+ distal 
tip lung epithelium contains individual multipotent 
embryonic progenitor cells. Development. 2009 
Nov;136(22):3741-5 
Schlegel NC, Eichhoff OM, Hemmi S, Werner S, Dummer 
R, Hoek KS. Id2 suppression of p15 counters TGF-beta-
mediated growth inhibition of melanoma cells. Pigment 
Cell Melanoma Res. 2009 Aug;22(4):445-53 
Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, 
Kawamoto H, Furusawa J, Ohtani M, Fujii H, Koyasu S. 
Innate production of T(H)2 cytokines by adipose tissue-
associated c-Kit(+)Sca-1(+) lymphoid cells. Nature. 2010 
Jan 28;463(7280):540-4 
Chakrabarti L, Wang BD, Lee NH, Sandler AD. A 
mechanism linking Id2-TGFβ crosstalk to reversible 
adaptive plasticity in neuroblastoma. PLoS One. 
2013;8(12):e83521 
Jensen K, Rother MB, Brusletto BS, Olstad OK, Dalsbotten 
Aass HC, van Zelm MC, Kierulf P, Gautvik KM. Increased 
ID2 levels in adult precursor B cells as compared with 
children is associated with impaired Ig locus contraction 
and decreased bone marrow output. J Immunol. 2013 Aug  
 
ID2 (inhibitor of DNA binding 2, dominant negative helix-loop-
helix protein) 
van Zelm MC 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2015; 19(3) 171 
1;191(3):1210-9 
Masson F, Minnich M, Olshansky M, Bilic I, Mount AM, 
Kallies A, Speed TP, Busslinger M, Nutt SL, Belz GT. Id2-
mediated inhibition of E2A represses memory CD8+ T cell 
differentiation. J Immunol. 2013 May 1;190(9):4585-94 
Verykokakis M, Krishnamoorthy V, Iavarone A, Lasorella 
A, Sigvardsson M, Kee BL. Essential functions for ID 
proteins at multiple checkpoints in invariant NKT cell 
development. J Immunol. 2013 Dec 15;191(12):5973-83 
Zhang B, Lin YY, Dai M, Zhuang Y. Id3 and Id2 act as a 
dual safety mechanism in regulating the development and 
population size of innate-like γδ T cells. J Immunol. 2014 
Feb 1;192(3):1055-63 
This article should be referenced as such: 
van Zelm MC. ID2 (inhibitor of DNA binding 2, dominant 
negative helix-loop-helix protein). Atlas Genet Cytogenet 
Oncol Haematol. 2015; 19(3):168-171. 
